|
Manufacturer¿s ref.No: (b)(4).Information regarding patient age, gender, weight, race, ethnicity, and medical history were not provided.Initial reporter information such as the name, phone and email address are unknown.Conclusion: the healthcare professional reported that during the coil embolization procedure of an aneurysm, the trufill dcs syringe (635002 / 96331305) was taken out of the package to be primed; after aspirating saline in the syringe, it was connected to the coil hub for priming and pressure was applied when a leak was found at the connection between the syringe and the tube tip.The trufill syringe was replaced and the procedure was completed without further issues or delay.There was no report of patient injury or complication; the complaint product was new and was stored per labeling instructions.The procedure was conducted in accordance with the instruction for use (ifu) with constant flush maintained at all time.There was no visible defect or damage noted on the product prior to the event.Based on complaint information, the device was not available to be returned for analysis.A review of the device history record (dhr) for this lot (96331305) confirmed that the product was manufactured under normal operating procedures.There were no non-conformances related to device manufacture or inspection.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of causes and possible contributing factors could be made.As such the investigation will be closed.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
The healthcare professional reported that during the coil embolization procedure of an aneurysm, the trufill dcs syringe (635002/96331305) was taken out of the package to be primed; after aspirating saline in the syringe, it was connected to the coil hub for priming and pressure was applied when a leak was found at the connection between the syringe and the tube tip.The trufill syringe was replaced and the procedure was completed without further issues or delay.There was no report of patient injury or complication; the complaint product was new and was stored per labeling instructions.The procedure was conducted in accordance with the instruction for use (ifu) with constant flush maintained at all time.There was no visible defect or damage noted on the product prior to the event.
|